$4.75
▲ +1.7% Today
as of Sep 4, 16:50 ET
Last 30 days
Recent Press Releases & News
Opus Genetics to Present OPGx-BEST1 Cohort 1 Clinical Data in Investor Webcast and at Upcoming Leading Ophthalmology Conferences
Opus Genetics shares rise 5.9% ahead of OPGx-BEST1 trial data
Opus Genetics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Overview
52-week range
$1.24
$5.81
77% of range
Avg surprise (last 3)
-103.6%
Avg reaction (last 2)
+0.6%
50% positive
Latest IV / EM
267%
EM ±41.8% · $5 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.14 | — | — | — | — | financials |
| Tue May 12, 2026 | Mar/2026 | $-0.75 | $-0.16 | -368.8% | -134.4% | +1.2% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.25 | — | — | — | — | financials |
| Wed Aug 13, 2025 | Jun/2025 | $-0.12 | $-0.25 | +52.0% | — | — | earnings |
| Thu May 15, 2025 | Mar/2025 | $-0.32 | $-0.34 | +5.9% | — | 0.0% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.29 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.30 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.29 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $0.25 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.24 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.28 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $755,000 | $2M | — | $3M | $3M | $4M | — | $4M |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-16M | $-14M | — | $-8M | $-9M | $-10M | — | $-8M |
| Net income | $-8M | $-66M | — | $-17M | $-7M | $-8M | — | $-8M |
| EPS (diluted) | $-0.14 | $-0.75 | — | $-0.25 | $-0.12 | $-0.24 | — | $-0.29 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $89M | $60M | $45M | $31M | $32M | $42M | $30M | $37M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $93M | $67M | $50M | $36M | $38M | $48M | $37M | $40M |
| Total assets | $93M | $67M | $50M | $36M | $39M | $48M | $37M | $40M |
| Long-term debt | $35M | $1M | $1M | $1M | $1M | — | $0 | — |
| Total liabilities | $106M | $88M | $35M | $30M | $21M | $24M | $11M | $6M |
| Total equity | $-13M | $-46M | $15M | $6M | $17M | $5M | $7M | $34M |